Introduction: Aripiprazole lauroxil (Aristada®) is a PLGA-based long-acting injectable antipsychotic that differs fundamentally from other LAI microsphere products: its payload […]
Introduction The development of generic long-acting injectables (LAIs) requires the establishment of qualitative, quantitative, and microstructural (Q1/Q2/Q3) equivalence to ensure
Common Failure Points in PLGA Microsphere Generic Development (and How to Solve Them) Read More »
Introduction to Comparative Testing Between Generic and RLD Comparative Testing Between Generic and RLD serves as a fundamental regulatory and
Comparative Testing Between Generic and RLD: Best Practices for ANDA Read More »
Introduction: Goserelin PLGA implant characterization is one of the most technically demanding challenges in long-acting parenteral development — and also
The Strategic Role of Biosimilar Characterization Services in Biopharmaceutical Approvals Biosimilar Characterization Services play a critical role in establishing analytical
Biosimilar Characterization Services Using Mass Spectrometry Read More »
Understanding the Regulatory Landscape of FDA Questions on E&L Studies The Food and Drug Administration (FDA) carefully evaluates extractables and
Introduction: Insulin analog characterization for generic ANDA is one of the most scientifically demanding challenges in the follow-on biologics space.
Introduction: Higher-order structure characterization of therapeutic peptides is no longer optional science — it is a regulatory and scientific imperative.
Maintaining a predictable Nitrosamine Testing Timeline has become a critical operational requirement for pharmaceutical manufacturers working to meet stringent compliance
How Long Does Nitrosamine Testing Take? Realistic Timelines by Study Type Read More »
Introduction to Interfacial Dynamics of Surfactants and Emulsifiers in PLGA Microsphere Fabrication The primary function of surfactants and emulsifiers in
Role of Surfactants and Emulsifiers in PLGA Microsphere Fabrication by Double Emulsion Read More »
